Ophenagen
Ophenagen is a Danish biotechnology company specializing in the development of innovative treatments for cancer and other serious diseases. Founded in 2015, the company is focused on advancing groundbreaking research in precision medicine to improve patient outcomes. Ophenagen's pipeline includes novel drug candidates that target specific genetic mutations associated with various forms of cancer.